European Journal of Anaesthesiology · 1997 · 46 citations · 15 references
MedicinePharmacologyPharmacotherapyAnesthesiaClinical PharmacologyPediatric PharmacotherapyAdverse Drug Event PreventionAntiemetic PharmacologyAntiemetic TherapyPostoperative VomitingVomiting ControlVomiting ManagementAntiemetic Efficacy EvaluationComparative Effectiveness Of AntiemeticsPediatric Antiemetic TherapyPediatric Postoperative VomitingPostoperative Vomiting In ChildrenPostoperative Vomiting ManagementProphylactic Antiemetic RegimensVomiting Episode
In this study the antiemetic effects of droperidol, ondansetron and their combination were evaluated in 160 ASA Grade I and II children undergoing surgery for strabismus, who were randomly assigned to one of four groups: Group D received droperidol 75 micrograms kg-1, group O ondansetron 0.1 mg kg-1, group D+O received both droperidol 75 micrograms kg-1 and ondansetron 0.1 mg kg-1, and group N NaCl as placebo. Emesis within the first 24 h occurred in 95.0% of the children with placebo medication, compared with 32.5% (D), 40.0% (O) and 45.0% (D+O) in the groups with antiemetic prophylaxis. The differences between group N and all other groups were significant (P < 0.001). However, there were no statistically significant differences between the groups D, O and D+O. It is concluded that droperidol (75 micrograms kg-1) and ondansetron (0.1 mg kg-1) both significantly reduce PONV in children undergoing surgery for strabismus. Neither ondansetron, nor the combination D+O were superior to droperidol alone.
15
Michel Marty, P Pouillart, Jean Pierre Droz et al. · New England Journal of Medicine · 1990 · 411 citations